-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

628.P1.20 628. Aggressive Lymphomas: Cellular Therapies: Poster I

Symposia: Aggressive Lymphomas: Cellular Therapies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Michael Wang, MD1, Patrick Connor Johnson, MD2, Salim Yazji, MD3*, Yisrael Katz, MD3*, Angela Pietrofeso3*, James Robinson, MS3*, Matthew Mei, MD4, Matthew J. Frigault, MD5*, James B. Breitmeyer, MD, PhD6 and Caron A. Jacobson, MD, MMSc7

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Massachusetts General Hospital Cancer Center, Boston, MA
3Oncternal Therapeutics, San Diego, CA
4City of Hope Cancer Center, Duarte, CA
5Massachusetts General Hospital, Boston, MA
6Oncternal Therapeutics, Inc, San Diego, CA
7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Pranav Santapuram1, Jason T Romancik, MD2, Jonathon B Cohen, MD MS3, Melissa Kives4*, Manali Rupji4*, Javier Pinilla-Ibarz, MD, PhD5, Kami J. Maddocks, MD6, Craig A. Portell, MD7, Joanna M. Rhodes, MD8 and Brian K. Link, MD9*

1Emory Winship Cancer Institute, Atlanta, GA
2Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
3Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
4Emory University, Atlanta, GA
5Moffitt Cancer Center, Tampa, FL
6The James Cancer Center, The Ohio State University, Columbus, OH
7Division of Hematology and Oncology, Department of Medicine, University of Virginia Medical Center, Charlottesville, VA
8Northwell Health Cancer Institute, Hoboken, NJ
9Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA

Na Zhang1*, Rui Liu1*, Fan Yang1*, Lixia Ma1*, Yuelu Guo1*, Zhonghua Fu1*, Haifeng Wu2*, Biping Deng, BS, MD3*, Xiaoyan Ke1* and Kai Hu, MD1

1Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Hospital, Beijing, China
2Department of Biostatistics, GoBroad Research Center, Shanghai, China
3Department of Cytology Laboratory, Beijing Gobroad Boren Hospital, Beijing, China

Roni Shouval, MD, PhD1,2, Teng Fei, PhD3*, Giulia Gabrielli, MD4,5,6*, Natalie Grier Smith, BA7,8*, Guido Ghilardi, MD5,9,10*, John Slingerland8*, Jonathan U. Peled, MD, PhD11,12,13, Ying Taur, MD13,14*, Sunita D. Nasta, MD10,15,16, Alejandro Luna, MD, PhD2*, Magdalena Corona, MD, PhD2*, Kai Rejeski, MD17,18, Sophia Stock, MD19,20,21*, Ronit Marcus, MD22*, Noa Golan Accav23*, Ofrat Beyar-Katz, MD, PhD24*, Hazim Khatib25*, Sandeep S. Raj, MD2, Alexander P. Boardman, MD13,26,27*, Parastoo B Dahi, MD11,13,26*, Richard J. Lin, MD, PhD13,18,26, Michael Scordo, MD11,13,26, Lorenzo Falchi, MD13,28, Jakub Svoboda, MD10,29,30, Elise A. Chong, MD5,10,31, Stefan K. Barta, MD10,32,33, Daniel J. Landsburg, MD10,31,34, Avichai Shimoni, MD23*, Arnon Nagler, MD23, Gunjan L. Shah, MD11,13,26, Maria Lia Palomba, MD26,35,36, Gilles Salles, MD, PhD26,36,37, Jae H. Park, MD1,26, Stephen J. Schuster, MD5,10,16, Tsila Zuckerman, MD38, Marion Subklewe, MD39, Abraham Avigdor, MD40, Miguel Angel Perales, MD2,41, Marcel R.M. van den Brink42,43* and Marco Ruella, MD5,9,10

1Department of Medicine, Weill Cornell Medicine, New York, NY
2Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
4Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
5Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
6Lymphoma Program, Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA
7Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
8City of Hope National Medical Center, Duarte, CA
9Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
10Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
11Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
12Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
13Department of Medicine, Weill Cornell Medical College, New York, NY
14Department of Medicine, Infectious Disease Service, Memorial Sloan-Kettering Cancer Center, New York, NY
15Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
16Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
17Hematology/Oncology, LMU University Hospital, Department of Medicine III, Munich, Germany
18Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
19Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
20Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany
21German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
22Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
23Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel
24Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus; The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
25Department of Hematology and Bone Marrow Transplantation,, Rambam Health Care Campus, Haifa, Israel
26Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
27Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY
28Memorial Sloan Kettering Cancer Center, New York, NY
29Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
30Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania,, Philadelphia, PA
31Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
32Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
33School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
34Center for Cellular Immunotherapies,, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
35Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
36Department of Medicine, Weill Cornell Medical College, New York
37Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York
38Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Moshav Ein Ayalla, Israel
39Department of Medicine III, LMU University Hospital, Munich, Germany
40Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
41Weill Cornell Medical College, New York, NY
42Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
43City of Hope National Medical Center, Duarte

Janneke W. De Boer, MD1*, Kylie Keijzer1,2*, Suzanne van Dorp3*, Pim G.N.J. Mutsaers, MD4*, Anne G.H. Niezink2*, Jaap A. van Doesum1*, Yasmina I.M. Serroukh5*, Louise W. Muntendam6*, Astrid E. Pulles6*, Esther J. Kret7*, Aniko Sijs-Szabo7*, Jesse Oomen3*, Astrid M.P. Demandt8*, Wendy B.C. Stevens3*, Maria T. Kuipers9,10*, Elise R.A. Pennings10,11,12,13*, Anne M. Spanjaart10,11,12*, Marie José Kersten10,11,12*, Margot Jak6*, Lisanne V. van Dijk2*, Marjolein W.M. van der Poel8*, Joost S.P. Vermaat7 and Tom van Meerten1*

1Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
2Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
3Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
4Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
5Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Leuven, Belgium
6Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
7Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
8Department of Internal Medicine, Division of Hematology, GROW school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands
9Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
10Cancer Center Amsterdam, Amsterdam, Netherlands
11LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, Netherlands
12Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
13Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands

Hazim Khatib, MD1*, Amit Parizat2*, Jabour Halloun, MD1*, Roni Shouval, MD, PhD3, Niveen Shibli1*, Onit Alalouf2*, Tsila Zuckerman, MD4,5, Nataly Vahaba1*, Iris Halamish6*, Danielle Sapir2*, Israel Henig, MD1*, Dana Yehudai-Ofir, MD1,4*, Shimrit Harlev1*, Netanel A. Horowitz, MD1,4*, Noa Lavi, MD1,4*, Nurit Horesh, MD1*, Riva Fineman, MD7*, Inna Tzoran, MD1,4*, Tsofia Levi, MD1*, Eldad J. Dann, MD1,4, Ahmad Mruwat1*, Benjamin Brenner1,4*, Ron Hoffman, MD1,4*, Ayal Rozenberg, MD4,8*, Yoav Shechtman, PhD2* and Ofrat Beyar-Katz, MD, PhD4,9*

1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
2Russel Berrie Nanotechnology Institute and Department of Biomedical Engineering, Technion, Haifa, Israel
3Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
5Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Moshav Ein Ayalla, Israel
6Computer Department, Rambam Health Care Campus, Haifa, Israel
7Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
8Department of Neurology, Rambam Health Care Campus, Haifa, Israel
9Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus; The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel

Bradley D. Hunter, MD, MPH, Daanish Hoda, Julie Asch, MD and Prashant Sharma, MD

LDS Hospital, Intermountain Health, Salt Lake City, UT

Guido Ghilardi, MD1,2,3,4*, Emeline R. Chong1,5*, Luca Paruzzo, MD4*, Giulia Gabrielli, MD6*, Sunita D. Nasta, MD1,7,8, Vrutti Patel9*, Eugenio Fardella, MD4*, Daniel J. Landsburg, MD10, Jordan Carter, MD11*, Colin Thomas, MD12, Stefan K. Barta, MD5,11,13, Elise A. Chong, MD1,7,14, Jakub Svoboda, MD1,8,11, Marco Ruella, MD1,4,9 and Stephen J. Schuster, MD1,8,9

1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
3Ente Ospedaliero Cantonale, Bellinzona, Switzerland
4Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
6Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
7Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
8Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
9Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
10Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
11School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
12Department of Medicine, University of Pennsylvania, Philadelphia, PA
13Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
14Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA

Jacob Garcia, MD, Christine Dehner*, Jeffrey Teoh, PhD* and Wayne Wallis, MD*

Umoja Biopharma, Seattle, WA

*signifies non-member of ASH